Drugs / STN1013600
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05665387 | Dec 2022 → Jul 2023 | presbyopia | Santen Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | STN1013600 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05665387 ↗ |